Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema

BACKGROUND: Approximately 50% of patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) report hives and angioedema; some experience hives/angioedema only. OBJECTIVE: Assess omalizumab's effect on angioedema and quality of life (QoL) in subgroups with refractory CIU/CSU: those with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurer, M., Sofen, H., Ortiz, B., Kianifard, F., Gabriel, S., Bernstein, J.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles and Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084322/
https://www.ncbi.nlm.nih.gov/pubmed/27911016
http://dx.doi.org/10.1111/jdv.14075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084322/
https://www.ncbi.nlm.nih.gov/pubmed/27911016
http://dx.doi.org/10.1111/jdv.14075

Ejemplares similares